Patient and Pathologic Characteristics
| TLG relative SD (%) for… | ||||||||||||
| Patient no. | Lesion | Location | Pathologic type | Volume for T40 (mL) | SUVmean for T40 (g/mL) | SUV relative SD (%) | TLG for T40 (g) | T40 | T50 | T60 | T70 | T80 |
| 1 | a | ULL | Small-cell lung cancer | 5.9 | 8.1 | 3.6 | 47.4 | 5.3 | 9.5 | 17.0 | 27.3 | 44.5 |
| b | 4R | 14.1 | 5.4 | 4.1 | 76.3 | 7.1 | 11.5 | 26.1 | 47.7 | 62.4 | ||
| 2 | LRL | Adenocarcinoma | 16.3 | 6.6 | 5.9 | 106.3 | 10.3 | 16.4 | 19.9 | 30.4 | 45.4 | |
| 3 | a | LLL | Small-cell lung cancer | 23.6 | 6.7 | 12.1 | 154.7 | 17.7 | 28.6 | 38.8 | 46.8 | 62.1 |
| b | 7 | 31.0 | 9.8 | 4.8 | 304.4 | 11.0 | 17.7 | 33.1 | 65.0 | 96.5 | ||
| 4 | a | URL | Large cell carcinoma | 7.9 | 13.0 | 4.5 | 102.6 | 4.0 | 6.6 | 8.5 | 13.5 | 22.8 |
| b | 7 | 13.7 | 11.5 | 4.5 | 157.0 | 4.1 | 6.0 | 10.9 | 25.9 | 53.9 | ||
| 5 | ULL | Small-cell lung cancer | 9.4 | 7.4 | 4.0 | 68.8 | 11.8 | 16.9 | 25.9 | 44.8 | 61.3 | |
| 6 | ULL | Squamous cell carcinoma | 31.9 | 8.4 | 4.3 | 266.3 | 3.4 | 5.0 | 10.5 | 19.4 | 25.4 | |
| 7 | LLL | Squamous cell carcinoma | 95.5 | 11.4 | 4.4 | 1086.3 | 7.4 | 9.6 | 12.9 | 25.0 | 55.4 | |
| 8 | ULL | Squamous cell carcinoma | 6.4 | 6.5 | 4.2 | 41.7 | 3.7 | 7.7 | 8.2 | 15.7 | 38.5 | |
| 9 | LLL | Large cell carcinoma | 7.6 | 9.3 | 4.5 | 70.8 | 7.7 | 11.0 | 14.4 | 24.2 | 34.6 | |
| 10 | ULL | Adenocarcinoma | 30.9 | 14.7 | 3.5 | 454.3 | 2.2 | 1.6 | 3.3 | 10.7 | 18.6 | |
| Mean | 22.6 | 9.1 | 5.0 | 225.9 | 7.4 | 11.4 | 17.6 | 30.5 | 47.8 | |||
T40, T50, T60, T70, and T80 = 40%, 50%, 60%, 70%, and 80% thresholds, respectively; ULL = upper left lobe; LRL = lower right lobe; LLL = lower left lobe, URL = upper right lobe.